Racard 2.5 mg (Tablet)
Unit Price: ৳ 4.60 (3 x 10: ৳ 138.00)
Strip Price: ৳ 46.00
Medicine Details
Category | Details |
---|---|
Generic | Ramipril |
Company | Pacific pharmaceuticals ltd |
Also available as |
Title and Categories
- Racard ACE Inhibitor
- Medicine
- Pharmaceutical Product
- Hypertension Treatment
Dimensions
N/A
Color Options
N/A
Functions
- Lowers Blood Pressure
- Manages Hypertension
- Treats Congestive Heart Failure
- Reduces Risk of Stroke and Myocardial Infarction
- Prevents Major Cardiovascular Events
- Long-acting Antihypertensive
- Effective in Heart Failure Management
- Reduces Vasopressor Activity
- Decreases Aldosterone Secretion
- Well Tolerated for Long-term Therapy
- Swallowable Tablets
- Absorption Not Affected by Food
- Prevents Angiotensin I Conversion to Angiotensin II
Materials
N/A
Technical Specifications
- Dosage: 1.25-20 mg daily
- Dosage Adjustment based on Patient Tolerance and Response
- Initial Dose for Hypertension: 1.25-2.5 mg once daily
- Initial Dose for Heart Failure: 2.5 mg twice daily
- Dose Titration for Heart Failure: Target 5 mg twice daily
- Dosage for Renal Impairment: 1.25-5 mg daily
- Dosage for Prevention of Major Cardiovascular Events: 2.5-10 mg daily
- Avoid Concomitant Use with Diuretics, Lithium, NSAIDs, Alcohol
- Contraindications for Use in Pregnancy, Angioedema, Hypotensive States, Renal Impairment, and Concomitant Medications
Design Elements
N/A
Usability Features
- Tablets must not be chewed or crushed
- Can be taken before, during, or after a meal
- Use with Sufficient Amounts of Liquid
- Well Tolerated with Common Side Effects like Dizziness, Headache, Fatigue, and Asthenia
- Rare Side Effects including Angioneurotic Edema, Anaphylactic Reactions, and Hyperkalemia
Interactions
- Serious Hypotension with Concomitant Diuretics
- Hyperlakemia with Potassium Sparing Diuretics
- Increased Serum Lithium Concentration with Concomitant Lithium Therapy
- Reduced Antihypertensive Effect with NSAIDs
- Avoid Driving and Operating Machinery with Reduced BP and Alcohol
Indications
- Treats Hypertension
- Manages Congestive Heart Failure
- Post-myocardial Infarction Heart Failure Treatment
- Treatment for Non-diabetic or Diabetic Overt Glomerular or Incipient Nephropathy
- Reduction of Cardiovascular Risk in High-risk Patients
Dosage
- Individualized Dosage Adjustment
- Initial Dose for Hypertension: 1.25-2.5 mg once daily
- Maintenance Dosage for Hypertension: 2.5-20 mg daily
- Initial Dose for Heart Failure after Myocardial Infarction: 2.5 mg twice daily
- Titration for Heart Failure: Target 5 mg twice daily
- Dosage for Prevention of Major Cardiovascular Events: 2.5-10 mg daily
- Special Dosage for Renal Impairment
Mode of Action
- Angiotensin Converting Enzyme (ACE) Inhibitor
- Decreased Plasma Angiotensin II Levels
- Decreased Vasopressor Activity and Aldosterone Secretion
Contraindications
- Hypersensitivity to Ramipril or ACE Inhibitors
- History of Angioedema
- Concomitant Use with Sacubitril/Valsartan Therapy
- Haemodynamically Relevant Renal Artery Stenosis
- Hypotensive or Haemodynamically Unstable States
- Concomitant Use with Aliskiren-containing Medicines or Angiotensin II Receptor Antagonists (AIIRAs)
- During Pregnancy
Side Effects
- Common: Dizziness, Headache, Fatigue, Asthenia
- Less Frequent: Symptomatic Hypotension, Cough, Nausea, Vomiting, Diarrhoea, Rash, Urticaria, Oliguria, Anxiety, Amnesia
- Rare: Angioneurotic Oedema, Anaphylactic Reactions, Hyperkalaemia
Pregnancy & Lactation
- Contraindicated during Pregnancy
- Pregnancy Exclusion before Treatment
- Avoid Pregnancy during ACE Inhibitor Treatment
- Not Recommended during Breastfeeding
Precautions & Warnings
- Caution in Impaired Renal Function, Hyperkalaemia, Hypotension, and Impaired Hepatic Function
Use in Special Populations
- Elderly: Consider Reduced Initial Dose
- Hepatic Impairment: Initiate Treatment under Close Medical Supervision
- Renal Impairment: Initial Daily Dose Consideration
- Patients Pretreated with Diuretics: Consideration for Discontinuation or Reduction of Diuretic Dose
Overdose Effects
- Symptoms: Hypotension, Shock, Bradycardia, Electrolyte Disturbances, Renal Failure
- Management: Detoxifcation by Gastric Lavage, Administration of adsorbents, Sodium Sulfate, Alpha1-adrenergic Agonists, Volume and Salt Substitution
Therapeutic Class
- Angiotensin-Converting Enzyme (ACE) Inhibitors
Storage Conditions
- Store at 30°C or below
- Protect from Light
- Keep out of reach of Children
- Do not use after Expiry Date
- Dispensed only on Prescription of a Registered Physician